The Asia-Pacific nasal spray market is set to record a CAGR of 10.18% during the forecast period, 2021-2028. Allergic Rhinitis (AR) is common in the Asia-Pacific. Also, aeroallergen exposure results in an increased risk of atopic diseases in the pediatric population. Moreover, allergic diseases are on the rise in the region, attributed to the dense population, environmental pollution, and extensive urbanization.

ASIA-PACIFIC NASAL SPRAY MARKET FORECAST 2021-2028

Asia Pacific Nasal Spray Market by Product (Decongestion Nasal Spray, Steroid Nasal Spray, Saltwater Solution/saline Nasal Spray) Market by Prescription (Over the Counter, Prescribed) Market by Therapeutic (Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor) Market by Application (Nasal Congestion, Allergic and Non-allergic Rhinitis, Vaccination, CNS Disorders, Other Applications) Market by End-user (Home Care Setting, ASC/clinics, Pharmacy, Hospital, Other End-users) by Geography.

Request free sample

The Asia-Pacific nasal spray market is set to record a CAGR of 10.18% during the forecast period, 2021-2028. Allergic Rhinitis (AR) is common in the Asia-Pacific. Also, aeroallergen exposure results in an increased risk of atopic diseases in the pediatric population. Moreover, allergic diseases are on the rise in the region, attributed to the dense population, environmental pollution, and extensive urbanization.asia-pacific-nasal-spray-market

To know more about this report, request a free sample copy.

The Asia-Pacific nasal spray market growth assessment includes the analysis of Vietnam, Japan, South Korea, China, Australia & New Zealand, Thailand, India, Indonesia, and Rest of Asia-Pacific. In China, allergic rhinitis (AR) is a serious public health and medical concern. It is a risk factor that causes several disorders and diseases, especially in children. Therefore, it is on the rise, significantly impacting the Chinese population. Also, chronic obstructive pulmonary disease (COPD) is a vastly prevalent disease. Biomass fuels and smoking are the major causes of the disease. In addition, it is the fifth leading cause of death in the country. As per the industry sources, there are more than 320 million smokers in China. As a result, COPD and smoking-related lung diseases are major epidemics in China.

In Indonesia, air pollution results in bronchitis, bronchial asthma, acute respiratory infection, lung cancer, etc. The air pollution problems are responsible for 50% of morbidity in Indonesia. Also, in September 2019, the country recorded 155 on the Air Quality Index. Moreover, air pollutants are becoming a high-risk factor for acute respiratory diseases among children. Such factors facilitate market growth in these countries.

Sun Pharmaceutical Industries Ltd offers a vast range of pharmaceutical formulations like generic pharmaceuticals and branded generics. Its products find applications in nephrology, cardiology, orthopedics, psychiatry, gastroenterology, etc. It provides products in different forms like inhalers, liquids, creams, ointments, injectables, capsules, and tablets. The company is headquartered in Mumbai, India.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING ADOPTION OF NASAL SPRAYS AMONG PATIENTS
        • GROWING ACCEPTANCE OF SELF-MEDICATION
        • INCREASING INTRANASAL VACCINES FOR COVID-19
      • KEY RESTRAINTS
        • OVERUSE RISKS ASSOCIATED WITH NASAL SPRAYS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON NASAL SPRAY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    3. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    4. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    5. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    6. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS
    7. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • AKORN INCORPORATED
        • ALLERGAN PLC
        • APOTEX INC
        • BHARAT BIOTECH
        • CATALENT INC
        • CIPLA LIMITED
        • GLAXOSMITHKLINE PLC
        • JOHNSON & JOHNSON
        • NOVARTIS INTERNATIONAL AG
        • PFIZER INC
        • PROCTOR & GAMBLE CO (P&G)
        • SANOTIZE RESEARCH AND DEVELOPMENT
        • SUN PHARMACEUTICALS INDUSTRIES LTD
        • TEVA PHARMACEUTICALS INDUSTRIES LTD
        • VIATRIS

     

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – NASAL SPRAY

    TABLE 2: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: KEY PLAYERS IN ASIA-PACIFIC NASAL SPRAY MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    FIGURE LIST

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA-PACIFIC NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 6: ASIA-PACIFIC NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA-PACIFIC NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA-PACIFIC NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA-PACIFIC NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020

    FIGURE 10: ASIA-PACIFIC NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA-PACIFIC NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020

    FIGURE 13: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

    FIGURE 14: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA-PACIFIC NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

    FIGURE 17: ASIA-PACIFIC NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 18: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

    FIGURE 19: ASIA-PACIFIC NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA-PACIFIC NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA-PACIFIC NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 22: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 23: ASIA-PACIFIC NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 24: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

    FIGURE 25: ASIA-PACIFIC NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 26: ASIA-PACIFIC NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 27: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

    FIGURE 28: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 29: ASIA-PACIFIC NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 30: CHINA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: JAPAN NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: INDIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: SOUTH KOREA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 34: INDONESIA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: THAILAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: VIETNAM NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: AUSTRALIA AND NEW ZEALAND NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: REST OF ASIA-PACIFIC NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • VIETNAM
          • AUSTRALIA & NEW ZEALAND
          • REST OF ASIA-PACIFIC
    1. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    2. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    3. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    4. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    5. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS

     

     

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type